Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-04-18

Clinical Trial Update: Fractional Laser in Combination With UVB Therapy in Vitiligo Patients [NA]

View source ↗

Summary

The clinical trial evaluating fractional laser in combination with UVB therapy for vitiligo has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Netherlands Institute for Pigment Disorders | Conditions: Vitiligo | NA | Status: WITHDRAWN